Matrix Private Capital Group LLC Novartis Ag Transaction History

Matrix Private Capital Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Feb 22, 2022	SELL	$81.78 - $95.14 $182,614 - $212,447	-2,233 Closed	0 $0
Q2 2021 Feb 22, 2022	BUY	$85.24 - $94.15 $190,340 - $210,236	2,233 New	2,233 $204,000
Q1 2021 Feb 22, 2022	SELL	$83.5 - $98.47 $186,622 - $220,080	-2,235 Closed	0 $0
Q4 2020 Feb 22, 2022	SELL	$78.07 - $94.43 $15,457 - $18,697	-198 Reduced 8.14%	2,235 $211,000
Q3 2020 Feb 22, 2022	SELL	$82.14 - $91.0 $574 - $637	-7 Reduced 0.29%	2,433 $212,000
Q2 2020 Feb 22, 2022	SELL	$80.93 - $91.1 $10,116 - $11,387	-125 Reduced 4.87%	2,440 $213,000
Q1 2020 Feb 22, 2022	SELL	$70.67 - $99.01 $77,454 - $108,514	-1,096 Reduced 29.94%	2,565 $211,000
Q4 2019 Feb 22, 2022	BUY	$84.35 - $95.37 $308,805 - $349,149	3,661 New	3,661 $347,000

1,434

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Matrix Private Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Matrix Private Capital Group LLC with notifications on news.